Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Daiichi Sankyo
Baxter
Julphar
AstraZeneca
Chubb
Chinese Patent Office
Teva
QuintilesIMS

Generated: October 23, 2017

DrugPatentWatch Database Preview

RECTIV Drug Profile

« Back to Dashboard

Which patents cover Rectiv, and when can generic versions of Rectiv launch?

Rectiv is a drug marketed by Forest Labs Inc and is included in one NDA.

The generic ingredient in RECTIV is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

Summary for Tradename: RECTIV

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list17
Clinical Trials: see list1
Patent Applications: see list2,292
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RECTIV at DailyMed

Pharmacology for Tradename: RECTIV

Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs Inc
RECTIV
nitroglycerin
OINTMENT;INTRA-ANAL021359-001Jun 21, 2011RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: RECTIV

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs Inc
RECTIV
nitroglycerin
OINTMENT;INTRA-ANAL021359-001Jun 21, 2011► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
UBS
AstraZeneca
Merck
Chinese Patent Office
Daiichi Sankyo
Novartis
Dow
McKinsey
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot